| UniProt ID | MTMRB_HUMAN | |
|---|---|---|
| UniProt AC | A4FU01 | |
| Protein Name | Myotubularin-related protein 11 | |
| Gene Name | MTMR11 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 709 | |
| Subcellular Localization | ||
| Protein Description | Probable pseudophosphatase. Contains a Glu residue instead of a conserved Cys residue in the dsPTPase catalytic loop which renders it catalytically inactive as a phosphatase (Potential).. | |
| Protein Sequence | MWWGGRGQSFNIAPQKEEPEMGSVQENRMPEPRSRQPSSCLASRCLPGEQILAWAPGVRKGLEPELSGTLICTNFRVTFQPCGWQWNQDTPLNSEYDFALVNIGRLEAVSGLSRVQLLRPGSLHKFIPEEILIHGRDFRLLRVGFEAGGLEPQAFQVTMAIVQARAQSNQAQQYSGITLSKAGQGSGSRKPPIPLMETAEDWETERKKQAARGWRVSTVNERFDVATSLPRYFWVPNRILDSEVRRAFGHFHQGRGPRLSWHHPGGSDLLRCGGFYTASDPNKEDIRAVELMLQAGHSDVVLVDTMDELPSLADVQLAHLRLRALCLPDSSVAEDKWLSALEGTRWLDYVRACLRKASDISVLVTSRVRSVILQERGDRDLNGLLSSLVQLLSAPEARTLFGFQSLVQREWVAAGHPFLTRLGGTGASEEAPVFLLFLDCVWQLLQQFPADFEFSEFFLLALHDSVRVPDTLTFLRNTPWERGKQSGQLNSYTQVYTPGYSQPPAGNSFNLQLSVWDWDLRYSNAQILQFQNPGYDPEHCPDSWLPRPQPSFMVPGPPSSVWLFSRGALTPLNQLCPWRDSPSLLAVSSRWLPRPAISSESLADQEWGLPSHWGACPLPPGLLLPGYLGPQIRLWRRCYLRGRPEVQMGLSAPTISGLQDELSHLQELLRKWTPRISPEDHSKKRDPHTILNPTEIAGILKGRAEGDLG | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 9 | Phosphorylation | WWGGRGQSFNIAPQK CCCCCCCCCCCCCCC | 24.08 | - | |
| 34 | Phosphorylation | NRMPEPRSRQPSSCL CCCCCCCCCCCCCCC | 46.08 | 24043423 | |
| 38 | Phosphorylation | EPRSRQPSSCLASRC CCCCCCCCCCCHHHC | 25.91 | 24043423 | |
| 39 | Phosphorylation | PRSRQPSSCLASRCL CCCCCCCCCCHHHCC | 21.60 | 24043423 | |
| 43 | Phosphorylation | QPSSCLASRCLPGEQ CCCCCCHHHCCCHHH | 15.58 | 28290473 | |
| 122 | Phosphorylation | VQLLRPGSLHKFIPE EEEECCCCHHHHCCH | 29.95 | - | |
| 218 | Phosphorylation | ARGWRVSTVNERFDV HCCCCEEEHHHCHHH | 25.21 | - | |
| 267 | Phosphorylation | SWHHPGGSDLLRCGG EECCCCCCCCEEECC | 30.88 | - | |
| 358 | Phosphorylation | RACLRKASDISVLVT HHHHHHHCCCEEEEE | 38.21 | 29396449 | |
| 361 | Phosphorylation | LRKASDISVLVTSRV HHHHCCCEEEEEHHH | 17.87 | 29396449 | |
| 478 | Phosphorylation | TLTFLRNTPWERGKQ HHHHHCCCCCHHCCC | 24.28 | 28348404 | |
| 588 | Phosphorylation | SPSLLAVSSRWLPRP CCCCEEEECCCCCCC | 14.47 | 28355574 | |
| 689 | Phosphorylation | SKKRDPHTILNPTEI CCCCCCCCCCCHHHH | 32.33 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MTMRB_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MTMRB_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MTMRB_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| AIFM1_HUMAN | AIFM1 | physical | 27880917 | |
| PYR1_HUMAN | CAD | physical | 27880917 | |
| COX41_HUMAN | COX4I1 | physical | 27880917 | |
| DNJA1_HUMAN | DNAJA1 | physical | 27880917 | |
| DNJA2_HUMAN | DNAJA2 | physical | 27880917 | |
| DNJA3_HUMAN | DNAJA3 | physical | 27880917 | |
| FKBP8_HUMAN | FKBP8 | physical | 27880917 | |
| IRS4_HUMAN | IRS4 | physical | 27880917 | |
| CCAR2_HUMAN | CCAR2 | physical | 27880917 | |
| LONM_HUMAN | LONP1 | physical | 27880917 | |
| MTM1_HUMAN | MTM1 | physical | 27880917 | |
| MTMR2_HUMAN | MTMR2 | physical | 27880917 | |
| TIM50_HUMAN | TIMM50 | physical | 27880917 | |
| TBB6_HUMAN | TUBB6 | physical | 27880917 |
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...